Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara, “ONO”) announced that it was continuously selected as a constituent stock in 5 investment indices for environmental, social and governance (ESG) selected by the Government Pension Investment Fund (GPIF), “MSCI Japan ESG Select Leaders Index”, “MSCI Japan Empowering Women Index (WIN)”, “FTSE Blossom Japan Index”, “S＆P/JPX Carbon Efficient Index” and “FTSE Blossom Japan Sector Relative Index” .
 In addition, Ono was selected as a constituent stock in “Morningstar Japan ex-REIT Gender Diversity Tilt Index (GenDi J)* newly adopted by GPIF in April 2023.

[ESG Investment Indices Selected by GPIF] *: (　) indicates the start date of operation

• MSCI Japan ESG Select Leaders Index (July 2017): 5 consecutive years from 2019
  From among the component companies of the MSCI Japan IMI top-700 Index, Japanese companies with outstanding ESG evaluations are selected.
• MSCI Japan Empowering Women Index (July 2017): 2 consecutive years from 2022
  From among the component companies of the MSCI Japan IMI top-700 Index, Japanese companies with outstanding gender diversity evaluations are selected.
• FTSE Blossom Japan Index series (July 2017): 6 consecutive years from 2018
  This index is designed by FTSE Russell, a member of the London Stock Exchange group. Japanese companies with excellent ESG practices are selected.
• S&P/JPX Carbon Efficient Index (September 2018): 6 consecutive years from 2018
  This index one of the ESG indices jointly developed by S&P Dow Jones Indices (S&P) and the Tokyo Stock Price Index (TOPIX). The weight of constituent is determined by the disclosure status of environmental information and carbon efficiency (Carbon emissions per unit of revenue) based on market capitalization.
• FTSE Blossom Japan Sector Relative Index (March 2022): 2 consecutive years from 2022
  The Index is developed by FTSE Russell. Japanese companies with excellent ESG practices are selected. The index is designated to be a sector neutral benchmark. In addition, in order to facilitate the transition to a low carbon economy, especially for those companies with particularly high greenhouse gas (GHG) emissions, the companies whose improvement efforts are evaluated by the Transition Pathway Initiative’s Management Quality Score are selected.
• Morningstar Japan ex-REIT Gender Diversity Tilt Index (GenDi J): First time in 2023

 Furthermore, ONO has been selected for six consecutive years since 2018 in the FTSE4Good Index Series, which is a benchmark for ESG investors that began operation in 2001 and selects companies with good ESG responses.

 Based on the corporate philosophy of “Dedicated to the Fight against Disease and Pain,” ONO continues to contribute to the sustainable development of society through the ESG perspective business activities and enhance sustainable corporate value.
 For details of the ONO group’s ESG initiatives, please refer to the following ONO’s Sustainability website: https://sustainability.ono-pharma.com/en

Morningstar Japan ex-REIT Gender Diversity Tilt Index (GenDi J):
Built with the data and scoring methodology of Equileap*, GenDi J is designed to emphasize the stocks of companies that have strong gender diversity policies embedded in their corporate culture and that ensure equal opportunities to employees, irrespective of their gender.
(Equileap is Headquartered in Amsterdam, Netherlands, Equileap is the leading provider of data and insights on gender equality in the corporate sector.)